ArticleFacts, views & vision in ObGyn2022

Homologous recombination repair deficiency (HRD) testing in newly diagnosed advanced-stage epithelial ovarian cancer: A Belgian expert opinion.

I Vergote et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.